Boehringer Ingelheim Tames the Dragon

Boehringer Ingelheim Tames the Dragon

by

Boehringer Ingelheim Tames the Dragon of GPP with Spevigo. The 2022 American Academy of Dermatology (AAD) saw the appearance of a unique disease state exhibit for Boehringer Ingelheim’s not-yet-approved drug to treat Generalized Pustular Psoriasis (GPP). The exhibit,...
TransMedics

TransMedics

by

TransMedics revolutionizes transplant processes. TransMedics works on streamlining organ transportation and doubling the inventory of available organs for transplant. Since 1986, one company, United Network for Organ Sharing (UNOS), has been alone in its work managing...
Boehringer Ingelheim (BI)

Boehringer Ingelheim (BI)

by

Boehringer-Ingelheim’s disease state exhibit explored the patient experience. Boehringer Ingelheim (BI) one of the world’s largest pharmaceutical companies, and the largest private one, has a drug in their pipeline to treat Generalized Pustular Psoriasis (GPP)....

Access@EXL

by

Return to All Case Studies Access@EXL When a pandemic interrupts the launch of a new brand identity Challenge The pandemic interrupted Access’ launch of its new brand identity. This exhibit, designed in 2019, finally made it to the show floor to continue the launch....

Pharmacosmos

by

Return to All Case Studies Pharmacosmos A global, clinical-stage biotechnology company developing and manufacturing novel therapies. Challenge Pharmacosmos, a Danish company, specializes in treating iron deficiency anemia. Pharmacosmos opened its first US-based office...